Unidade Local De Saude De Amadora Sintra E.P.E.

At Unidade Local De Saude De Amadora Sintra E.P.E., the Serviço de Nefrologia is involved in studies focused on immune system diseases and male and female urogenital conditions, with a strong emphasis on kidney disease. Research includes focal segmental glomerulosclerosis and related proteinuric disorders, aiming to evaluate new treatments that may reduce kidney damage and improve long-term renal outcomes.

• Studies in focal segmental glomerulosclerosis and other protein-losing kidney disorders
• Research on treatment options designed to lower proteinuria and protect kidney function
• Clinical evaluation of therapies for chronic renal conditions linked to immune-mediated disease

This work reflects the site’s broader interest in improving care for patients with complex nephrology conditions through new therapeutic approaches.

A major part of the research portfolio at this hospital centers on neoplasms, especially breast cancer. Trials are studying early and advanced disease across ER-positive, HER2-positive, HER2-low, and triple negative breast cancer, with the goal of improving recurrence prevention, disease control, and treatment effectiveness.

• Research in early-stage and metastatic breast cancer
• Studies testing new cancer therapies and combinations to improve survival and delay progression
• Trials aimed at preventing recurrence and refining treatment choices for different tumor subtypes

The oncology program also includes studies in ovarian cancer and other advanced solid tumors, supporting a broad effort to improve outcomes in difficult-to-treat cancers.

The site is also active in respiratory tract diseases, with trials in severe asthma, metastatic non-small cell lung cancer, and interstitial lung disease secondary to systemic sclerosis. These studies are designed to better control symptoms, assess lung function, and explore new options for both chronic inflammatory and cancer-related lung conditions.

• Asthma research focused on improving symptom control and reducing flare-ups
• Studies in non-small cell lung cancer examining new treatment strategies
• Investigation of systemic sclerosis-related interstitial lung disease to support breathing and preserve lung capacity

This respiratory research adds an important dimension to the site’s clinical trial activity in chronic and advanced lung diseases.

Another key area is immune system diseases, especially systemic lupus erythematosus. Trials are evaluating whether new therapies can better reduce disease activity and support long-term safety in patients living with this complex autoimmune condition.

• Studies in systemic lupus erythematosus focused on disease control and treatment safety
• Research aimed at reducing immune-driven inflammation and improving quality of life
• Ongoing evaluation of long-term treatment tolerability in chronic autoimmune disease

This work highlights the site’s interest in therapies that may offer more durable benefit for patients with persistent inflammatory disease.

The clinical trial program at Unidade Local De Saude De Amadora Sintra E.P.E. includes cardiovascular diseases and type 2 diabetes, with studies looking at stroke prevention, heart failure risk, and broader cardiovascular protection in people with metabolic disease. These trials aim to improve outcomes in patients at elevated risk of serious heart and vascular events.

• Trials in stroke prevention after acute ischemic events
• Research in type 2 diabetes with and without established cardiovascular disease
• Studies evaluating whether new treatment strategies can lower major cardiovascular complications

This therapeutic area links metabolic care with vascular risk reduction, an important focus for patients with long-term chronic disease.

The site also contributes to virus diseases research, including HIV-1 infection. These studies are exploring new treatment approaches for people who have not yet received therapy, with the aim of improving viral control and simplifying care.

• Studies in HIV-1 infection for treatment-naive patients
• Research focused on evaluating new antiviral options and treatment convenience
• Clinical work supporting better long-term management of chronic viral disease

This area broadens the site’s research profile beyond specialty medicine into important infectious disease care.